This story was originally published Feb. 23.
Caliper Life Sciences and Covaris said today they will co-market Caliper's automated workstation tools and Covaris' DNA-fragmentation technology.
Covaris uses proprietary Adaptive Focus Acoustics technology to fragment DNA, which the company said is highly controlled, reproducible, precise, and amenable to automation.
The agreement is a "logical next step" for Caliper because many laboratories are already using both Covaris' shearing technology with Caliper's tools like the Sciclone NGS Workstation, Caliper CEO Kevin Hrusovsky said in a statement.
"As sequencing technologies move from the lab bench to the clinic, it is critical that integrated solutions offer consistency and sample tracking," he added.
Caliper has recently inked deals with several companies in the next-gen sequencing space. In Februrary, it said it would co-develop with NuGen Technologies automated sample-prep methods, and that its first product, a method for constructing an RNA-seq library with as little as 500 picograms of total RNA, would be available in March (IS 2/1/2011). In October, it signed a deal with Illumina to co-market Caliper's LabChip XT and LabChip GX platforms for sequencing sample prep (IS 10/26/2010).
Financial terms of the agreement were not disclosed.